Dermatology Grand Rounds
Dermatology Lecture Hall
Wednesday, Jan. 20th, 8am-12pm
676 North Saint Clair Street, Suite 1600 (16th Floor)
Overall meeting objectives:
At the conclusion of this activity, participants should be able to:
1. Discuss new technology used in addressing dermatologic problems.
2. Understand the choices and risks for treating skin disease.
3. Discuss the ethical issues that arise in patient care.
4. Recognize the relevance of new laboratory discoveries to clinical issues.
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement:
The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure: Amy S. Paller, MD, MS has disclosed the following relevant financial relationships:
Serves as a consultant (with honoraria ) for the following companies: AbbVie, Anacor Pharmaceuticals, Inc., Celgene Corporation, Chugai Pharma, Galderma Laboratories, L.P. LEO Pharma US, Novartis Pharmaceuticals Corp., Onset Dermatologics, Promius Pharma, LLC., Scioderm, Shire, and Stiefel a GSK company.
Serves as a Principal Investigator (no honoraria) for the following companies: Amgen, Anacor Pharmaceuticals, Inc., Scioderm, and TopMD.
FSM’s listed CME Leadership and Staff have nothing to disclose: John X. Thomas, Jr., PhD, Sr. Associate Dean for Medical Education, Genevieve Napier, CME Director, Jen Banys, Michelle Mallery, and Tristan Brown, CME Project Specialists.
Robert Galiano, MD has nothing to disclose.
Rochelle R. Torgerson, MD has nothing to disclose.
Sponsored by: Department of Dermatology